Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies
medical device investing Knight Therapeutics Announces Health Canada Approval for JORNAY PM to Treat Attention-Deficit Hyperactivity Disorder
medical device investing Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
QIMC Announces Thermogenic Wet-Gas Signature in 86% of Soil-Gas Samples at New Salem-Apple River, Nova Scotia, Next to Its 30% Clean Hydrogen Discovery
Standard Uranium Initiates Partner Funded Surface Exploration Program at the Corvo Uranium Project, Eastern Athabasca Basin, Saskatchewan
Brixton Metals Drills 4 m of 1,975 g/t Silver within 23.50 m of 348 g/t Silver in Hole 449 at its Langis Project in Ontario